Virtu KCG Holdings LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 95 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu KCG Holdings LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2017$151,000
-69.7%
24,329
-69.1%
0.00%
-71.4%
Q1 2017$499,000
-46.9%
78,667
-55.2%
0.01%
-39.1%
Q4 2016$940,000
+93.0%
175,772
+98.0%
0.02%
+130.0%
Q2 2016$487,000
-6.3%
88,793
+42.0%
0.01%
+11.1%
Q4 2015$520,000
+29.4%
62,525
+40.2%
0.01%
+28.6%
Q3 2015$402,000
+156.1%
44,611
+206.1%
0.01%
+133.3%
Q1 2015$157,000
+57.0%
14,573
-61.7%
0.00%
+50.0%
Q3 2014$100,000
+6.4%
38,016
+62.4%
0.00%
+100.0%
Q2 2014$94,000
-9.6%
23,416
+2.4%
0.00%0.0%
Q1 2014$104,000
+57.6%
22,865
+37.4%
0.00%0.0%
Q3 2013$66,00016,6460.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2014
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders